Caption Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-403,200
Closed -$40.9M 1685
2025
Q4
$40.9M Buy
403,200
+355,100
+738% +$28.5M 0.28% 77
2025
Q3
$2.63M Sell
48,100
-28,400
-37% -$1.42M 0.02% 734
2025
Q2
$4.07M Buy
+76,500
New +$3.89M 0.05% 462
2025
Q1
Sell
-521,700
Closed -$29.3M 1674
2024
Q4
$29.3M Buy
+521,700
New +$32.5M 0.28% 49
2024
Q2
Sell
-325,400
Closed -$22.5M 1265
2024
Q1
$22.5M Buy
325,400
+246,000
+310% +$15.6M 0.34% 56
2023
Q4
$5.87M Buy
79,400
+35,300
+80% +$2.31M 0.08% 290
2023
Q3
$3.01M Sell
44,100
-105,100
-70% -$8.92M 0.05% 479
2023
Q2
$14M Buy
149,200
+124,200
+497% +$9.69M 0.25% 96
2023
Q1
$1.7M Sell
25,000
-218,200
-90% -$14M 0.03% 490
2022
Q4
$12M Buy
+243,200
New +$9.94M 0.19% 133
2022
Q3
Sell
-500
Closed -$20K 1604
2022
Q2
$20K Sell
500
-130,000
-100% -$6.95M ﹤0.01% 1369
2022
Q1
$9.13M Buy
130,500
+61,500
+89% +$4.5M 0.11% 245
2021
Q4
$5.37M Buy
+69,000
New +$6.09M 0.06% 432
2021
Q1
Sell
-93,600
Closed -$12.4M 1150
2020
Q4
$12.4M Buy
93,600
+83,600
+836% +$10.1M 0.28% 89
2020
Q3
$1.02M Hold
10,000
0.02% 610
2020
Q2
$869K Sell
10,000
-28,600
-74% -$2.29M 0.03% 567
2020
Q1
$2.24M Sell
38,600
-232,900
-86% -$18.9M 0.13% 226
2019
Q4
$25.1M Buy
271,500
+146,500
+117% +$12.9M 0.84% 16
2019
Q3
$11.3M Buy
125,000
+75,000
+150% +$8.55M 0.59% 34
2019
Q2
$5.9M Sell
50,000
-43,000
-46% -$4.33M 0.3% 92
2019
Q1
$8.06M Sell
93,000
-36,100
-28% -$3.07M 0.44% 59
2018
Q4
$8.15M Buy
129,100
+104,100
+416% +$7.14M 0.65% 33
2018
Q3
$1.97M Hold
25,000
0.11% 229
2018
Q2
$1.49M Hold
25,000
0.12% 203
2018
Q1
$1.01M Sell
25,000
-175,000
-88% -$8.54M 0.14% 154
2017
Q4
$10.5M Buy
+200,000
New +$10.7M 1.09% 24

Other funds holding EXAS

Caption Management's EXAS Position: Q1 2026 in Review

Caption Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 170,679 shares — an estimated $17.3M sold.

Caption Management first reported a position in EXAS in Q4 2018 and held it in 14 quarters. The position peaked at $17.3M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Caption Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 170,679 Exact Sciences shares in Q1 2026, an estimated $17.3M.
  • Caption Management first reported a position in Exact Sciences in Q4 2018 and held it in 14 quarters.
  • Caption Management's Exact Sciences position peaked at $17.3M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.